Cesar R. Alcala-Orozco

Cesar R. Alcala-Orozco

Auto-generated profile, based on publicly available information

Cesar R. Alcala-Orozco

University of Otago 1

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 May 2018 in Biofabrication
Verified
Journal Article
Closed access
PDF file
Khoon LimKhoon Lim
Khoon Lim
RLRiccardo Levato
Riccardo Levato
Pedro CostaPedro Costa
Pedro Costa
Miguel CastilhoMiguel Castilho
Miguel Castilho
CACesar R Alcala-Orozco
Cesar R Alcala-Orozco
TWTim Woodfield
Tim Woodfield
Lithography-based three-dimensional (3D) printing technologies allow high spatial resolution that exceeds that of typical extrusion-based bioprinting approaches, allowing to better mimic the complex architecture of biological tissues. Additionally, lithographic printing via digital light processing (DLP) enables fabrication of free-form lattice and patterned structures which cannot be easily produced with other 3D printing approaches. While significant progress has been dedicated to the development of cell-laden bioinks for extrusion-based bioprinting, less attention has been directed towards the development of cyto-compatible bio-resins and their application in lithography-based biofabrication, limiting the advancement of this promising technology. In this study, we developed a new bio-resin based on methacrylated poly(vinyl alcohol) (PVA-MA), gelatin-methacryloyl (Gel-MA) and a transition metal-based visible light photoinitiator. The utilization of a visible light photo-initiating system displaying high molar absorptivity allowed the bioprinting of constructs with high resolution features, in the range of 25–50 μ m. Biofunctionalization of the resin with 1 wt% Gel-MA allowed long term survival (>90%) of encapsulated cells up to 21 d, and enabled attachment and spreading of endothelial cells seeded on the printed hydrogels. Cell-laden hydrogel constructs of high resolution with complex and ordered architecture were successfully bioprinted, where the encapsulated cells remained viable, homogenously distributed and functional. Bone and cartilage tissue synthesis was confirmed by encapsulated stem cells, underlining the potential of these DLP-bioprinted hydrogels for tissue engineering and biofabrication. Overall, the PVA-MA/Gel-MA bio-resin is a promising material for biofabrication and provides important cues for the further development of lithography-based bioprinting of complex, free-form living tissue analogues.

12 June 2019 in Biofabrication
Verified
Journal Article
Closed access
PDF file
GCGianluca Cidonio
Gianluca Cidonio
CACesar R Alcala-Orozco
Cesar R Alcala-Orozco
Khoon LimKhoon Lim
Khoon Lim
MGMichael Glinka
Michael Glinka
Isha MutrejaIsha Mutreja
Isha Mutreja
RORichard Oreffo
Richard Oreffo
Bioprinting of living cells is rapidly developing as an advanced biofabrication approach to engineer tissues. Bioinks can be extruded in three-dimensions (3D) to fabricate complex and hierarchical constructs for implantation. However, a lack of functionality can often be attributed to poor bioink properties. Indeed, advanced bioinks encapsulating living cells should: (i) present optimal rheological properties and retain 3D structure post fabrication, (ii) promote cell viability and support cell differentiation, and (iii) localise proteins of interest (e.g. vascular endothelial growth factor (VEGF)) to stimulate encapsulated cell activity and tissue ingrowth upon implantation. In this study, we present the results of the inclusion of a synthetic nanoclay, Laponite ® (LPN) together with a gelatin methacryloyl (GelMA) bioink and the development of a functional cell-instructive bioink. A nanocomposite bioink displaying enhanced shape fidelity retention and interconnected porosity within extrusion-bioprinted fibres was observed. Human bone marrow stromal cell (HBMSC) viability within the nanocomposite showed no significant changes over 21 days of culture in LPN-GelMA (85.60 ± 10.27%), compared to a significant decrease in GelMA from 7 (95.88 ± 2.90%) to 21 days (55.54 ± 14.72%) ( p < 0.01). HBMSCs were observed to proliferate in LPN-GelMA with a significant increase in cell number over 21 days ( p < 0.0001) compared to GelMA alone. HBMSC-laden LPN-GelMA scaffolds supported osteogenic differentiation evidenced by mineralised nodule formation, including in the absence of the osteogenic drug dexamethasone. Ex vivo implantation in a chick chorioallantoic membrane model, demonstrated excellent integration of the bioink constructs in the vascular chick embryo after 7 days of incubation. VEGF-loaded LPN-GelMA constructs demonstrated significantly higher vessel penetration than GelMA-VEGF ( p < 0.0001) scaffolds. Integration and vascularisation was directly related to increased drug absorption and retention by LPN-GelMA compared to LPN-free GelMA. In summary, a novel light-curable nanocomposite bioink for 3D skeletal regeneration supportive of cell growth and growth factor retention and delivery, evidenced by ex vivo vasculogenesis, was developed with potential application in hard and soft tissue reparation.

15 January 2020 in Advanced Healthcare Materials
Verified
Journal Article
Closed access
PDF file
XCXiaolin Cui
Xiaolin Cui
BSBram G. Soliman
Bram G. Soliman
CACesar R. Alcala‐Orozco
Cesar R. Alcala‐Orozco
JLJun Li
Jun Li
MVMichelle A. M. Vis
Michelle A. M. Vis
Khoon LimKhoon Lim
Khoon Lim

1 June 2020 in Bioprinting
Verified
Journal Article
Closed access
CACesar R. Alcala-Orozco
Cesar R. Alcala-Orozco
Isha MutrejaIsha Mutreja
Isha Mutreja
XCXiaolin Cui
Xiaolin Cui
Dhiraj KumarDhiraj Kumar
Dhiraj Kumar
GHGary J. Hooper
Gary J. Hooper
TWTim Woodfield
Tim Woodfield

12 April 2022 in Biofabrication
Verified
Journal Article
Closed access
XCXiaolin Cui
Xiaolin Cui
CACesar R Alcala-Orozco
Cesar R Alcala-Orozco
KBKenzie Baer
Kenzie Baer
JLJun Li
Jun Li
CMCaroline A Murphy
Caroline A Murphy
TWTim Woodfield
Tim Woodfield
Recently developed modular bioassembly techniques hold tremendous potential in tissue engineering and regenerative medicine, due to their ability to recreate the complex microarchitecture of native tissue. Here, we developed a novel approach to fabricate hybrid tissue-engineered constructs adopting high-throughput microfluidic and 3D bioassembly strategies. Osteochondral tissue fabrication was adopted as an example in this study, because of the challenges in fabricating load bearing osteochondral tissue constructs with phenotypically distinct zonal architecture. By developing cell-instructive chondrogenic and osteogenic bioink microsphere modules in high-throughput, together with precise manipulation of the 3D bioassembly process, we successfully fabricated hybrid engineered osteochondral tissue in vitro with integrated but distinct cartilage and bone layers. Furthermore, by encapsulating allogeneic umbilical cord blood-derived mesenchymal stromal cells, and demonstrating chondrogenic and osteogenic differentiation, the hybrid biofabrication of hydrogel microspheres in this 3D bioassembly model offers potential for an off-the-shelf, single-surgery strategy for osteochondral tissue repair.